The risk of sympathetic ophthalmia associated with open globe injury management strategies: a meta-analysis.

医学 眼内容剜除术(眼科) 交感性眼炎 剜除术 荟萃分析 外科 置信区间 相对风险 眼科 内科学 葡萄膜炎 病理 替代医学
作者
Tim J. Patterson,Adam Kedzierski,David McKinney,Jonathan Ritson,Chris McLean,Weidong Gu,Marcus H. Colyer,Scott McClellan,Sarah C. Miller,Grant A. Justin,Annette K. Hoskin,Kara M. Cavuoto,James Leong,Andrés Rousselot Ascarza,Fasika A. Woreta,Kyle Miller,Matthew Caldwell,William G. Gensheimer,Thomas H. Williamson,Felipe Dhawahir-Scala,Peter Shah,Andrew Coombes,Gangadhara Sundar,Robert A. Mazzoli,M. Woodcock,Stephanie L. Watson,Ferenc Kuhn,Sophia Halliday,Renata S. M. Gomes,Rupesh Agrawal,Richard J. Blanch
出处
期刊:Ophthalmology [Elsevier BV]
标识
DOI:10.1016/j.ophtha.2023.12.006
摘要

Topic Sympathetic ophthalmia (SO) is a sight threatening granulomatous panuveitis caused by a sensitizing event. The use of primary enucleation or primary evisceration, versus primary repair, as a risk management strategy following OGI remains controversial. Clinical relevance This systematic review was conducted to report the incidence of SO after primary repair compared to after primary enucleation or primary evisceration. This enabled the reporting of an estimated number needed to treat (NNT). Methods Five journal databases were searched. This review was registered with PROSPERO: CRD42021262616. Searches were carried out on 29th June 2021 and updated 10th Dec 2022. Prospective or retrospective studies which reported outcomes (including sympathetic ophthalmia or lack of sympathetic ophthalmia) in a patient population who underwent either primary repair and primary enucleation, or primary evisceration, were included. A systematic review and meta-analysis were carried out in accordance with PRISMA guidelines. PROSPERO registration number CRD42021262616. Random effects modelling was used to estimate pooled SO rates and absolute risk reduction (ARR). Results Eight studies reporting SO as an outcome were included in total. The included studies contained 7500 patients and 7635 OGIs. In total 7620 OGIs met the criteria for inclusion in this analysis; 21 developed SO. When all included studies were pooled, the estimated SO rate was 0.12% (95% confidence interval (CI) 0.00% to 0.25%) after OGI. Out of 779 patients who underwent primary enucleation or primary evisceration no SO cases were reported, resulting in pooled SO estimate of 0.05% (95% CI 0.00% – 0.21%). For primary repair, the pooled estimate of SO rate was 0.15% (95% CI 0.00% to 0.33%). The ARR using a random effects model was -0.0010 (in favour of eye removal) (95% CI -0.0031 (in favour of eye removal) to 0.0011 (in favour of primary repair)). GRADE analysis highlighted a low certainty of evidence, as the included studies were observational and there was a risk of bias from missing data. Conclusion Based on the available data, there is no evidence that primary enucleation or primary evisceration reduce the risk of secondary SO.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
陳拾壹完成签到 ,获得积分10
3秒前
学术悍匪发布了新的文献求助10
5秒前
我是老大应助nn采纳,获得20
7秒前
王祉萱发布了新的文献求助10
7秒前
猪猪hero应助布丁采纳,获得10
7秒前
7秒前
大个应助公孙世往采纳,获得10
7秒前
徐徐发布了新的文献求助10
8秒前
深情安青应助Yy采纳,获得10
9秒前
DD完成签到,获得积分10
11秒前
人间烟火发布了新的文献求助10
13秒前
15秒前
DD发布了新的文献求助10
17秒前
18秒前
Persist发布了新的文献求助10
19秒前
19秒前
554802336完成签到,获得积分20
20秒前
22秒前
22秒前
22秒前
23秒前
orixero应助小李子采纳,获得10
24秒前
日出发布了新的文献求助10
27秒前
人间烟火完成签到,获得积分10
28秒前
Yy发布了新的文献求助10
29秒前
量子星尘发布了新的文献求助10
32秒前
小鹦鹉完成签到 ,获得积分10
33秒前
wang完成签到,获得积分10
33秒前
小田完成签到,获得积分10
35秒前
小鹦鹉关注了科研通微信公众号
38秒前
41秒前
43秒前
44秒前
bkagyin应助废式脂肪采纳,获得10
45秒前
lili发布了新的文献求助10
46秒前
47秒前
春花发布了新的文献求助10
50秒前
51秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976418
求助须知:如何正确求助?哪些是违规求助? 3520512
关于积分的说明 11203586
捐赠科研通 3257127
什么是DOI,文献DOI怎么找? 1798594
邀请新用户注册赠送积分活动 877804
科研通“疑难数据库(出版商)”最低求助积分说明 806523